Adalimumab in Psoriasis: How Much Is Enough?-Reference-Cited by-同舟云学术

Adalimumab in Psoriasis: How Much Is Enough?

Published:2019-01 Issue:1 Volume:139 Page:19-22
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Billi Allison C.,Gudjonsson Johann E.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference14 articles.

1. Innovation and competition: will biosimilars succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety;Blackstone;Biotechnol Healthc,2012

2. TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis;Conrad;Nat Commun,2018

3. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease;Feuerstein;Gastroenterology,2017

4. Comment on 'Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study': reply from authors;Mahil;Br J Dermatol,2013

5. Developing a therapeutic range of adalimumab serum concentrations in management of psoriasis: a step toward personalized treatment;Menting;JAMA Dermatol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience;Journal of Investigative Dermatology;2023-09

2. Biologics for the Management of Erythrodermic Psoriasis: An Updated Review;Clinical, Cosmetic and Investigational Dermatology;2023-08

3. Increasing to weekly adalimumab dosing leads to improved psoriasis outcomes—A retrospective single‐centre review of real‐world data;Journal of the European Academy of Dermatology and Venereology;2022-10-10

4. Xenobiotic Receptor CAR Is Highly Induced in Psoriasis and Promotes Keratinocyte Proliferation;Journal of Investigative Dermatology;2021-12

5. Biomarkers of Inflammation in Obesity-Psoriatic Patients;Mediators of Inflammation;2019-05-28